Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/1/25 18:44 | 3/28/25 | CATX | Health | MdEq | Surgical & Medical Instrument | Spoor Johan M. | WA | DO | CEO | 4 | P | 308 | 1.91 | 0 | 161 | 221 | 234 | M | ||||||||||||||
4/1/25 17:04 | 1/30/24 | CATX | Health | MdEq | Surgical & Medical Instrument | Williamson Robert F III | WA | D | 5 | P.m | 362 | 1.30 | 0 | 279 | 180 | 434 | D | |||||||||||||||
4/1/25 17:03 | 3/28/25 | CATX | Health | MdEq | Surgical & Medical Instrument | Graham Juan | WA | O | CFO | 1 | P | 75 | 2.25 | 0 | 33 | 999% | 35 | D | ||||||||||||||
4/1/25 17:03 | 3/31/25 | CATX | Health | MdEq | Surgical & Medical Instrument | Woods Lori A | WA | D | 3 | P | 150 | 2.41 | 0 | 62 | 4 | 1,554 | I | |||||||||||||||
12/6/24 16:05 | 12/4/24 | CATX | Health | MdEq | Surgical & Medical Instrument | Henson Heidi | WA | D | 1 | P | 100 | 3.85 | 0 | 26 | 26 | I | ||||||||||||||||
11/27/24 07:00 | 11/25/24 | CATX | Health | MdEq | Surgical & Medical Instrument | Hunt Jonathan Robert | WA | O | CFO | 3 | P | 102 | 2.56 | 0 | 40 | 13 | 342 | D | ||||||||||||||
3/8/24 11:24 | 3/6/24 | CATX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lantheus Alpha Therapy, LLC | MA | T | 1 | P | 57,409 | 0.9500 | 0 | 60,431 | 107 | 116,773 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |